The Personalized Insights™ report offers guidance on which drugs are likely to work best for you, and which you should avoid (based on increased risk of side effects or drug interactions), so you and your healthcare team can manage your health condition(s) as effectively and safely as possible. The reports are available on our secure portal so that you can easily share your reports with others.

Your Inagene Personalized Insights™ Report doesn’t provide disease risk information, but rather describes your unique predicted response to medications commonly used to treat a variety of pain and mental health conditions, and other conditions (eg. cardiology, oncology, gastroenterology, etc.). Depending on which test you order, you may get a report on your predicted response to over 200 medications. The results are specific to individual medications (not health conditions), so the recommendations apply regardless of what type of pain, mental health, or other health conditions the drug is being used to treat.

The recommendations in Inagene’s report are taken directly from published pharmacogenetic recommendations (publicly available) from several well-recognized, government-funded governing bodies that have been established over the past two decades in the USA, Europe, and Asia. Research over the last three decades has generated an overwhelming amount of evidence that genetic variation plays a major role in how individuals respond to different drugs. These include the Food and Drug Administration (FDA), Clinical Pharmacogenetics Implementation Consortium (CPIC), the Pharmacogenomics Knowledge Base (PharmGKB), EMA (European Medicines Agency), Health Canada, and the Dutch Pharmacogenetics Working Group (DPWG). If you are interested in learning more about these recommendations, your report will have direct links to our sources where you can learn more about the validated science.